Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-047522
Filing Date
2011-05-09
Accepted
2011-05-09 17:19:43
Documents
3
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c16812e10vq.htm 10-Q 158050
2 EXHIBIT 31.1 c16812exv31w1.htm EX-31.1 9129
3 EXHIBIT 32.1 c16812exv32w1.htm EX-32.1 3837
  Complete submission text file 0000950123-11-047522.txt   171989
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 11824499
SIC: 2834 Pharmaceutical Preparations